China's CanSino Biologics said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as...
CanSinoBIO's shot uses a modified common cold virus known as adenovirus type-5 (Ad5) to carry genetic material from the coronavirus protein into the body
The letter penned by Sindh Health Department has asked the CanSino bio company to share the schedule of delivery of as many as 10 million COVID vaccine doses with Sindh.